Fundamentals screen · refreshed after the Nov 10, 2026 close
Largest US companies: Healthcare
US-listed companies ranked by market capitalisation. Market capitalisation is shares outstanding multiplied by the latest close.
| # | Company | Price | Today | YTD | P/E | Mkt cap |
|---|---|---|---|---|---|---|
| 401 | INDPIndaptus TherapeuticsHealthcare | $2.90 | −7.35% | −0.3% | — | $386.4M |
| 402 | ALTAltimmuneHealthcare | $1.94 | −8.49% | −46.3% | — | $377.4M |
| 403 | ALECAlectorHealthcare | $2.53 | +2.85% | +62.2% | 9.2× | $376.7M |
| 404 | FENCFennec PharmaceuticalsHealthcare | $10.58 | −2.31% | +37.4% | — | $371.0M |
| 405 | EMBCEmbectaHealthcare | $6.43 | +0.31% | −45.9% | 4.2× | $364.3M |
| 406 | DTILPrecision BioSciencesHealthcare | $9.50 | −1.86% | +128.4% | — | $362.6M |
| 407 | SPRYARS PharmaceuticalsHealthcare | $3.57 | +13.33% | −69.4% | — | $358.9M |
| 408 | GALTGalectin TherapeuticsHealthcare | $3.38 | −2.31% | −18.8% | — | $340.9M |
| 409 | VMDViemed HealthcareHealthcare | $8.98 | +0.34% | +20.9% | 21.8× | $340.3M |
| 410 | CVCapsoVisionHealthcare | $6.37 | −1.09% | −40.4% | — | $338.9M |
| 411 | AVIRAtea PharmaceuticalsHealthcare | $4.20 | −4.76% | +17.6% | — | $337.3M |
| 412 | FTHFaeth TherapeuticsHealthcare | $12.92 | +1.89% | — | — | $333.9M |
| 413 | EIKNEikon TherapeuticsHealthcare | $6.13 | +4.43% | — | — | $332.0M |
| 414 | XFORX4 PharmaceuticalsHealthcare | $3.25 | −2.55% | −18.9% | — | $331.4M |
| 415 | SCTXScribe TherapeuticsHealthcare | $17.36 | +4.08% | — | — | $328.7M |
| 416 | ENTAEnanta PharmaceuticalsHealthcare | $11.22 | −2.18% | −28.9% | — | $326.8M |
| 417 | BNTCBenitec BiopharmaHealthcare | $9.28 | −5.98% | −31.1% | — | $323.8M |
| 418 | ALLOAllogene TherapeuticsHealthcare | $0.9319 | −12.08% | −32.0% | — | $322.9M |
| 419 | SSIISS Innovations InternationalHealthcare | $1.61 | −13.90% | −71.7% | — | $322.8M |
| 420 | OCGNOcugenHealthcare | $0.9500 | −2.27% | −29.6% | — | $322.3M |
| 421 | TMCITreace Medical ConceptsHealthcare | $4.88 | +2.09% | +99.2% | — | $319.9M |
| 422 | PEPGPepGenHealthcare | $4.61 | +92.89% | −29.2% | — | $319.3M |
| 423 | AGENAgenusHealthcare | $7.02 | −1.82% | +123.6% | 10.8× | $317.6M |
| 424 | KYTXKyverna TherapeuticsHealthcare | $5.08 | −1.74% | −46.0% | — | $314.2M |
| 425 | CABACabaletta BioHealthcare | $1.45 | −3.33% | −33.8% | — | $312.8M |
| 426 | EBSEmergent BiosolutionsHealthcare | $6.05 | −0.82% | −51.1% | — | $311.1M |
| 427 | INFUInfuSystem HoldingsHealthcare | $15.28 | +4.09% | +70.3% | 35.8× | $306.1M |
| 428 | CYHCommunity Health SystemsHealthcare | $2.17 | −3.98% | −30.4% | 8.5× | $306.0M |
| 429 | IPSCCentury TherapeuticsHealthcare | $1.68 | −7.18% | +68.9% | — | $304.2M |
| 430 | TTRXTurn TherapeuticsHealthcare | $9.92 | +1.33% | +151.8% | — | $301.2M |
| 431 | PRLDPrelude Therapeutics IncorporatedHealthcare | $3.76 | 0.00% | +29.7% | — | $300.1M |
| 432 | NAUTNautilus BiotechnolgyHealthcare | $2.32 | −2.52% | +19.0% | — | $295.5M |
| 433 | SMTISanara MedTechHealthcare | $31.66 | −1.37% | +35.6% | — | $290.9M |
| 434 | OFIXOrthofix Medical Inc. Common Stock (DE)Healthcare | $7.12 | −9.87% | −53.0% | — | $290.1M |
| 435 | VOGXVogenxHealthcare | $19.26 | +5.02% | — | — | $286.1M |
| 436 | EVMNEvommuneHealthcare | $7.84 | +2.48% | −54.2% | — | $284.5M |
| 437 | FULCFulcrum TherapeuticsHealthcare | $3.72 | 0.00% | −67.1% | — | $284.1M |
| 438 | PROFProfound MedicalHealthcare | $7.68 | +4.63% | −2.4% | — | $281.3M |
| 439 | CLPTClearPoint NeuroHealthcare | $8.77 | −4.36% | −35.9% | — | $281.1M |
| 440 | LRMRLarimar TherapeuticsHealthcare | $2.69 | +6.32% | −29.4% | — | $279.4M |
| 441 | QTTBQ32 BioHealthcare | $9.33 | −0.11% | +181.0% | 8.7× | $279.2M |
| 442 | SABSSAB BiotherapeuticsHealthcare | $3.07 | −0.97% | −17.9% | — | $276.6M |
| 443 | CAMPCAMP4 TherapeuticsHealthcare | $4.33 | −7.68% | −29.4% | — | $271.7M |
| 444 | ARCTArcturus Therapeutics HoldingsHealthcare | $9.39 | −1.05% | +53.2% | — | $270.6M |
| 445 | RCKTRocket PharmaceuticalsHealthcare | $2.45 | −3.16% | −30.2% | — | $268.9M |
| 446 | BIOABioAge LabsHealthcare | $5.78 | +1.58% | −56.3% | — | $265.6M |
| 447 | LCTXLineage Cell TherapeuticsHealthcare | $1.04 | −3.70% | −37.7% | — | $263.0M |
| 448 | LABStandard BioToolsHealthcare | $0.6650 | −4.21% | −48.0% | 2.0× | $262.5M |
| 449 | KLCKinderCare Learning CompaniesHealthcare | $2.21 | −5.15% | −48.8% | — | $261.9M |
| 450 | LXEOLexeo TherapeuticsHealthcare | $3.06 | −2.55% | −69.2% | — | $251.2M |
Method & sources
Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology
Informational screen, not a recommendation.